MedPath

Iliac Angioplasties: Impact of the Fusion of Images on the Irradiation Rate

Not Applicable
Conditions
Irradiation Rate
Image, Body
Iliac Artery Disease
Registration Number
NCT05353309
Lead Sponsor
Ramsay Générale de Santé
Brief Summary

Atherosclerosis can cause the arteries to narrow (stenosis) or clog (occlude), leading to reduced blood flow.

Arteriography or angiography is a radiological examination of the arteries which will make it possible to confirm and quantify the severity of the damage to the artery and which, in certain cases, can be directly treated by angioplasty with or without stenting (selective angioplasty).

Digital subtraction angiography (DSA), the reference technique, provides good image quality. The fluoroscopy used today during angioplasty procedures makes it possible to obtain images in real time and to guide the progression of the endovascular material in the arterial axis. Image fusion is an established technique for the endovascular treatment of aortic aneurysms. The feasibility of image fusion for the iliac arterial axes has already been assessed and is reproducible. However, there is no assessment of the irradiation rate in iliac angioplasty, using intraoperative image fusion, compared to standard angioplasty practices.

Detailed Description

Atherosclerosis can cause the arteries to narrow (stenosis) or clog (occlude), leading to reduced blood flow. Iliac stenosis can be asymptomatic or symptomatic. Clinical manifestations are related to the degree of narrowing. The symptoms are in order of increasing severity: pain in the legs when walking (intermittent claudication), at rest, even foot or leg ulcers.

Arteriography or angiography is a radiological examination of the arteries requiring the injection of contrast product which will make it possible to confirm and quantify the severity of the damage to the artery and which, in certain cases, can be directly treated by angioplasty with or without stenting (selective angioplasty).

Digital subtraction angiography (DSA), the reference technique, provides good image quality. The fluoroscopy used today during angioplasty procedures makes it possible to obtain images in real time and to guide the progression of the endovascular material in the arterial axis. Image fusion is an established technique for the endovascular treatment of aortic aneurysms. The feasibility of image fusion for the iliac arterial axes has already been assessed and is reproducible. However, there is no assessment of the irradiation rate in iliac angioplasty, using intraoperative image fusion, compared to standard angioplasty practices.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
350
Inclusion Criteria
  • Patient, male or female, over the age of 18
  • Patient with a primary and/or external iliac lesion (TASC A, B and C)
  • Patient for whom unilateral angioplasty is indicated
  • Affiliated patient or beneficiary of a social security scheme
  • Patient having been informed and having signed a written consent.
Exclusion Criteria
  • Patient with a BMI strictly less than 18.5 or greater than or equal to 30.0 kg/m²
  • Patient with long iliac thrombosis (including the primitive iliac and the external iliac)
  • Patient with a known allergy to iodine
  • Patient with a contraindication related to the procedure
  • Patient for whom a bilateral iliac procedure is indicated
  • Patient requiring an associated infra-inguinal endovascular procedure
  • Patient participating in another clinical study
  • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
  • Pregnant, breastfeeding or parturient women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Irradiation rate"immedialtely at the end of surgery procedure"

mean irradiation rate during iliac angioplasty will be compared between the 2 study groups The primary endpoint of the research is the patient's intraoperative irradiation rate defined by measuring the dose area product (DAP) in Gy.cm2

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

CHU de Nantes

🇫🇷

Nantes, Bretagne, France

Saint Martin Private Hospital

🇫🇷

Caen, Normandy, France

CHU de Nantes
🇫🇷Nantes, Bretagne, France
Blandine Maurel, Dr
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.